Weight-loss drug Wegovy offers benefits for people with diabetes and common form of heart failure, study finds

The weight loss drug Wegovy may have additional health benefits for individuals with diabetes and a certain type of heart failure, according to a recent study. The drug was found to be effective in helping people with Type 2 diabetes and obesity-related heart failure with preserved ejection fraction. This condition is characterized by the heart pumping regularly but being too stiff to fill properly. Currently, there are no approved therapies for this specific condition. The study showed that participants who took Wegovy experienced improved outcomes, including weight loss, reduction in heart failure symptoms, and increased physical capabilities. The drug also resulted in fewer adverse events compared to the placebo group. The study suggests that Wegovy could be a safe and effective treatment option for a wide range of individuals, including those with diabetes.